Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Chiao-Fang Teng"'
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 923 (2023)
Hepatocellular carcinoma (HCC) is one of the most frequent and life-threatening human cancers worldwide. Despite curative resection surgery, the high recurrence rate of HCC leads to poor patient survival. Chronic hepatitis B virus (HBV) infection is
Externí odkaz:
https://doaj.org/article/2d0a6b63b2a74b9d89c3de6a065b5522
Autor:
Chiao-Fang Teng, Tsai-Chung Li, Ting Wang, Da-Ching Liao, Yi-Hsuan Wen, Tzu-Hua Wu, John Wang, Han-Chieh Wu, Woei-Cherng Shyu, Ih-Jen Su, Long-Bin Jeng
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Hepatocellular carcinoma (HCC) is a frequent and deadly human cancer worldwide that is intimately associated with chronic hepatitis B virus (HBV) infection. Pre-S2 mutant is a HBV oncoprotein that plays important roles in HCC development and
Externí odkaz:
https://doaj.org/article/89de2542f60a4160bff8882c63d2210e
Publikováno v:
Cancers, Vol 15, Iss 4, p 1005 (2023)
Hepatocellular carcinoma (HCC) is the predominant form of primary liver cancer. Although many surgical and nonsurgical therapeutic options have been established for treating HCC, the overall prognosis for HCC patients receiving different treatment mo
Externí odkaz:
https://doaj.org/article/d980e4af3f3744fe91886732a9f85504
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 19, p 11781 (2022)
In addition to the fundamental role of insulin-like growth factor (IGF)/IGF-1 receptor (IGF-1R) signaling dysregulation in cancer initiation and proliferation, the IGF/IGF-1R signaling also plays an important role in the maintenance of stem cell char
Externí odkaz:
https://doaj.org/article/d2c6257e09a54226ad9787ba14b6ef80
Publikováno v:
Cancers, Vol 14, Iss 18, p 4380 (2022)
Although many surgical and nonsurgical therapeutic options have been well-established, hepatocellular carcinoma (HCC) remains the third most common cause of cancer-related death worldwide. Therefore, the discovery of novel potential therapeutic strat
Externí odkaz:
https://doaj.org/article/81ee3ac86c084f35921cae2ea8cbf3be
Publikováno v:
Viruses, Vol 14, Iss 6, p 1346 (2022)
Although surgical resection is available as a potentially curative therapy for hepatocellular carcinoma (HCC), high recurrence of HCC after surgery remains a serious obstacle for long-term patient survival. Therefore, the discovery of valuable progno
Externí odkaz:
https://doaj.org/article/d1e8a9cb40c44395a0c73a92f76f2011
Autor:
Chiao-Fang Teng, Hsi-Yuan Huang, Tsai-Chung Li, Woei-Cherng Shyu, Han-Chieh Wu, Chien-Yu Lin, Ih-Jen Su, Long-Bin Jeng
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Abstract Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Early diagnosis and treatment of HCC remain a key goal for improving patient survival. Chronic hepatitis B virus (HBV) infection is a major risk factor for
Externí odkaz:
https://doaj.org/article/c5011b5735bb42fd90994eecf15d6f47
Publikováno v:
Viruses, Vol 14, Iss 2, p 428 (2022)
Hepatocellular carcinoma (HCC) is among the most common and lethal human cancers worldwide and is closely associated with chronic hepatitis B virus (HBV) infection. Pre-S deleted proteins are naturally occurring mutant forms of HBV large surface prot
Externí odkaz:
https://doaj.org/article/787cf3f7b4384d1daf74bd43a8760665
Autor:
Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu, Jia-Hui Lin, Fu-Ying Shih, Woei-Cherng Shyu, Long-Bin Jeng
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Hepatocellular carcinoma (HCC) is among the most common and lethal human cancers worldwide. Despite remarkable advances in treatment, high mortality in HCC patients remains a big challenge. To develop novel therapeutic strategies for HCC
Externí odkaz:
https://doaj.org/article/b9840db16c464ebd8532deeb32a13b68
Autor:
Chiao-Fang Teng, Hung-Wen Tsai, Tsai-Chung Li, Ting Wang, John Wang, Woei-Cherng Shyu, Han-Chieh Wu, Ih-Jen Su, Long-Bin Jeng
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234773 (2020)
Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related death worldwide. Patients with hepatitis B virus (HBV) pre-S mutants in liver tissues or blood have been regarded as a high-risk population for HCC development and recurrenc
Externí odkaz:
https://doaj.org/article/cdd4ced260b145f9bdb9510ad17c00d6